Classification
- Anatomical main groupVVarious
- Therapeutic subgroupV03
- Pharmacological subgroupV03A
- Chemical subgroupV03AC
- Chemical substanceV03AC02Deferiprone
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
EMA · 3 medicines
AIFA · 3 medicines
PHARMAC · 3 medicines
FDA · 3 medicines
Anvisa · 2 medicines
AEMPS · 2 medicines
HALMED · 2 medicines
SFDA · 2 medicines · Historical list
HSA · 2 medicines
TFDA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
32 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Deferiprone | United States | 1GM, 500MG | tablet | Marketed | Senores Pharms |
| Deferiprone Doc | Italy | Compressa rivestita con film | Authorised | Doc Generici SRL | |
| Deferiprone Lipomed | European Union | Authorised | Lipomed GmbH | ||
| Deferiprone Lipomed | Italy | Compressa rivestita con film | Authorised | Lipomed GMBH | |
| Deferiprone Lipomed 500 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Lipomed GmbH | |
| Taro-Deferiprone | Canada | 1000 MG | Tablet | Marketed | Taro Pharmaceuticals INC |
| Ferriprox | United States | 1GM, 500MG | tablet | Marketed | Chiesi |
| Ferriprox | United States | 100MG/ML, 80MG/ML | solution | Marketed | Chiesi |
| Deferipron Lipomed | Croatia | Authorised | |||
| Ferriprox | European Union | Authorised | Chiesi Farmaceutici S.p.A. | ||
| Ferriprox | Italy | Compressa rivestita con film | Authorised | Chiesi Farmaceutici S.P.A. | |
| Ferriprox | Canada | 100 MG / ML | Solution | Marketed | Chiesi Canada Corp. |
| Ferriprox | Canada | 500 MG | Tablet | Marketed | Chiesi Canada Corp. |
| Ferriprox | Canada | 1000 MG | Tablet | Marketed | Chiesi Canada Corp. |
| Ferriprox 100 MG/ML Solucion Oral | Spain | 100 mg | solución oral | Marketed | Chiesi Farmaceutici S.P.A. |
| Ferriprox MR | Canada | 1000 MG | Tablet (Extended-Release) | Marketed | Chiesi Canada Corp. |
| Ferriprox | Brazil | Authorised | Chiesi Farmacêutica Ltda | ||
| FERRIPROX 500 mg COMPRIMIDOS CON CUBIERTA PELICULAR | Spain | 500 mg | comprimido recubierto | Marketed | Chiesi Farmaceutici S.P.A. |
| Ferriprox BD | Brazil | Authorised | Chiesi Farmacêutica Ltda | ||
| Ferriprox, 500 mg filmomhulde tabletten | Netherlands | Tablet | Authorised | Chiesi Farmaceutici S.p.A. | |
| Ferriprox 1000 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Chiesi Farmaceutici S.p.A. | |
| Ferriprox 100 mg/ml, vloeistof voor oraal gebruik | Netherlands | Vloeistof voor oraal gebruik | Authorised | Chiesi Farmaceutici S.p.A. | |
| Ferriprox | Croatia | Marketed | |||
| Ferriprox | New Zealand | Oral liq 100 mg per 1 ml | Funded | ||
| Ferriprox | New Zealand | Oral liq 100 mg per ml | Funded |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.